Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.

Huai Leng PisanielloSusan LesterDavid Gonzalez-ChicaNigel StocksMarie LongoGreg R SharplinEleonora Dal GrandeTiffany K GillSamuel L WhittleCatherine L Hill

Published in: Arthritis research & therapy (2018)

Despite gout being a common, potentially disabling joint disease, only 55% of respondents with gout in this study adhered to ULT. Identification of key predictors of ULT use will provide guidance on prescribing strategy in clinical practice and on the quality of gout care in the community.

Keyphrases

uric acid
clinical practice
healthcare
primary care
metabolic syndrome
quality improvement
palliative care
risk factors
stem cells
mesenchymal stem cells
health insurance
electronic health record
bioinformatics analysis
affordable care act
drug induced